Literature DB >> 18234368

Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells.

Jian-an Wang, Aina He, Xinyang Hu, Yun Jiang, Yong Sun, Jun Jiang, Chun Gui, Yaping Wang, Han Chen.   

Abstract

OBJECTIVE: We hypothesized that anoxic preconditioning (AP) could enhance the cardioprotective effect of mesenchymal stem cells (MSCs).
METHODS: Myocardial infarction (MI) was set up in Sprague-Dawley rats and left ventricles were randomly injected with the following: DMEM, MSCs and AP-MSCs. Cardiac function was assessed by echocardiography 4 weeks after transplantation, hematoxylin-eosin staining and Masson trichrome were performed subsequently.
RESULTS: Increased fractional shortening, ejection fraction and decreased infarct size were observed most obviously in AP-MSCs group, accompanied by increased arteriole density and cell survival.
CONCLUSIONS: AP enhanced the capacity of MSCs to repair infarcted myocardium, attributable to increased cell survival and angiogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 18234368     DOI: 10.1016/j.ijcard.2007.11.096

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

1.  Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells.

Authors:  Simi M Chacko; Shabnam Ahmed; Karuppaiyah Selvendiran; M Lakshmi Kuppusamy; Mahmood Khan; Periannan Kuppusamy
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

Review 2.  Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.

Authors:  Diptiman Chanda; Sanjay Kumar; Selvarangan Ponnazhagan
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

3.  The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart.

Authors:  Yeyou Liang; Qiuxiong Lin; Jiening Zhu; Xiaohong Li; Yongheng Fu; Xiao Zou; Xiaoying Liu; Honghong Tan; Chunyu Deng; Xiyong Yu; Zhixin Shan; Weiwei Yuan
Journal:  Mol Cell Biochem       Date:  2014-07-25       Impact factor: 3.396

4.  Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions.

Authors:  Trivia P Frazier; James B McLachlan; Jeffrey M Gimble; Hugh A Tucker; Brian G Rowan
Journal:  Stem Cells Dev       Date:  2014-03-11       Impact factor: 3.272

Review 5.  Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.

Authors:  Andrey A Karpov; Daria V Udalova; Michael G Pliss; Michael M Galagudza
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

Review 6.  Cell based therapies for ischemic stroke: from basic science to bedside.

Authors:  Xinfeng Liu; Ruidong Ye; Tao Yan; Shan Ping Yu; Ling Wei; Gelin Xu; Xinying Fan; Yongjun Jiang; R Anne Stetler; George Liu; Jieli Chen
Journal:  Prog Neurobiol       Date:  2013-12-12       Impact factor: 11.685

7.  Matrix remodeling as stem cell recruitment event: a novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix.

Authors:  Joshua Mauney; Bjorn R Olsen; Vladimir Volloch
Journal:  Matrix Biol       Date:  2010-09-07       Impact factor: 11.583

Review 8.  Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration.

Authors:  Debayon Paul; Samson Mathews Samuel; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 9.  Preconditioning strategy in stem cell transplantation therapy.

Authors:  Shan Ping Yu; Zheng Wei; Ling Wei
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

10.  Benefits of hypoxic culture on bone marrow multipotent stromal cells.

Authors:  Chih-Chien Tsai; Tu-Lai Yew; Der-Chi Yang; Wei-Hua Huang; Shih-Chieh Hung
Journal:  Am J Blood Res       Date:  2012-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.